Article
PCSK9 and breast cancer survival: a Mendelian Randomization study
2025-10-05
Abstract excerpt
<h4>Background</h4> Proprotein convertase subtilisin/kexin type 9 (PCSK9) is well known for its causal effects on the lipid metabolism. A recent study identified an association between rs562556 within PCSK9 and breast cancer survival (BCS). It was suggested that PCSK9 inhibition might allow for early intervention strategies to prevent metastasizing breast cancer. Here, we attempt to replicate these findings by us...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 18333db6-42d1-5472-92f9-469fe8c6a24d
- DOI
- 10.1101/2025.10.03.25337270
